At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZLAB Zai Lab Ltd
Trading 04-29 12:47:23 EDT
20.69
-1.45
-6.55%
High21.62Low20.66Vol263.99K
Open21.62D1 Closing22.14Amplitude4.34%
Mkt Cap2.32BTradable Cap2.26BTotal Shares112.35M
T/O5.55MT/O Rate0.24%Tradable Shares109.37M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

CICC Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
TIPRANKS  ·  04-25
CICC Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
Guotai Haitong Sticks to Their Buy Rating for Zai Lab Ltd (1ZLB)
TIPRANKS  ·  04-24
Guotai Haitong Sticks to Their Buy Rating for Zai Lab Ltd (1ZLB)
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
MT Newswires Live  ·  04-23
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
Jefferies Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  04-23
Jefferies Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
Press Release: Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026
Dow Jones  ·  04-22
Press Release: Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026
Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)
TIPRANKS  ·  04-21
Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)
Zai Lab Shares Climb Over 5% on Positive Preclinical Data for ZL-1503
Stock News  ·  04-20
Zai Lab Shares Climb Over 5% on Positive Preclinical Data for ZL-1503
Zai Lab presents new preclinical data on ZL-1503
TIPRANKS  ·  04-20
Zai Lab presents new preclinical data on ZL-1503
Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting
MT Newswires Live  ·  04-18
Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
TIPRANKS  ·  04-18
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  04-16
Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
Zai Lab Shares Climb Over 4% on Partnership with Boehringer Ingelheim for Novel Dual DLL3-Targeting Combination Therapy
Stock News  ·  04-16
Zai Lab Shares Climb Over 4% on Partnership with Boehringer Ingelheim for Novel Dual DLL3-Targeting Combination Therapy
Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
MT Newswires Live  ·  04-15
Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
Zai Lab Shares Climb Over 3% Following Global Clinical Partnership with Amgen for Zoci Candidate
Stock News  ·  04-14
Zai Lab Shares Climb Over 3% Following Global Clinical Partnership with Amgen for Zoci Candidate
Zai Lab Ltd (1ZLB) Receives a Buy from CICC
TIPRANKS  ·  04-11
Zai Lab Ltd (1ZLB) Receives a Buy from CICC
Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)
Simply Wall St.  ·  04-11
Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)
Zai Lab Grants Stock Options, Restricted Share Units, and Performance Share Units
Stock News  ·  04-02
Zai Lab Grants Stock Options, Restricted Share Units, and Performance Share Units
Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen
Deep News  ·  04-02
Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen
Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment
Stock News  ·  04-02
Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment
Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading
MT Newswires Live  ·  04-01
Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

Introduction

Company Name.
Zai Lab Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Issue price:
--